Medications

Report: Remdesivir dominated hospital drug spending in 2021

The COVID-19 treatment remdesivir dominated hospital drug spending in 2021, accounting for nearly 10% of all pharmaceutical expenses and outpacing the next three drugs combined, according to the National Trends in Prescription ...

Medications

FDA outlines path for lower-priced biotech drugs

(AP) -- The Food and Drug Administration is preparing to review the first lower-cost versions of biotech drugs, expensive medications which have never before faced generic competition.

HIV & AIDS

Two-thirds of Myanmar HIV patients untreated: MSF

International funding cuts threaten to deepen an HIV crisis in Myanmar, where tens of thousands of people are denied lifesaving treatment, an aid agency said Wednesday.

Arthritis & Rheumatism

Report: Musculoskeletal disorders costly for society

More money was spent on musculoskeletal disorders, such as osteoarthritis and back pain, than any other disease, condition or injury in Australia, suggests a new report from the Australian Institute of Health and Welfare ...

page 7 from 40